A265 (2025-26 session)
NY State bill
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.
- Title
- Relates to the availability of opioid reversal agents
- Type
- New York State Assembly bill
- Session
- 2025-26 session
- Status
- In Senate Committee
- Latest action date
- 2026-01-12
- In committee
- Alcoholism And Substance Use Disorders
- Introduced
- 2024-12-31
- Active version
- A265A
- Same as
- S4150
- Law section
- Mental Hygiene Law
Sponsors
Co-sponsors
Heard in committee
- Alcoholism and Drug Abuse NY State Assembly committee
- Rules NY State Assembly committee
- Ways and Means NY State Assembly committee
- Alcoholism And Substance Use Disorders NY State Senate committee
Same as
- S4150 (2025-26 session) NY State bill